Description
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that causes substantial physical, emotional, and psychological burden. Guselkumab, a monoclonal antibody that binds to the p19 subunit of interleukin-23, has demonstrated high levels of efficacy for the treatment of inflammatory diseases, including psoriasis and psoriatic arthritis.